DEK::AFF2 Fusion Carcinomas of Head and Neck
- PMID: 36221219
- DOI: 10.1097/PAP.0000000000000376
DEK::AFF2 Fusion Carcinomas of Head and Neck
Abstract
A novel DEK::AFF2 fusion carcinoma was recently described in 29 patients who originally presented with non-viral-associated nonkeratinizing squamous cell carcinoma. The tumors occurred at multiple sites in the head and neck including in the sinonasal tract, middle ear, and temporal bone. This tumor behaves aggressively involving adjacent vital structures, frequently recurs, and is inclined to develop lymph node and distant metastasis. This review aims to summarize the demographic, clinical, pathologic, immunophenotypic features, and pattern of molecular alterations as well as to discuss the differential diagnosis of DEK::AFF2 fusion carcinoma.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors have no funding or conflicts of interest to disclose.
References
-
- Van Dijk BA, Gatta G, Capocaccia R, et al. RARECARE Working Group. Rare cancers of the head and neck area in Europe. Eur J Cancer. 2012;48:783–796.
-
- Dutta R, Dubal PM, Svider PF, et al. Sinonasal malignancies: a population-based analysis of site-specific incidence and survival. Laryngoscope. 2015;125:2491–2497.
-
- Binazzi A, Corfiati M, Di Marzio D, et al. Sinonasal cancer in the Italian national surveillance system: epidemiology, occupation, and public health implications. Am J Ind Med. 2018;61:239–250.
-
- Thompson LDR, Bishop JA. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Nasal Cavity, Paranasal Sinuses and Skull Base. Head Neck Pathol. 2022;16:1–18.
-
- Yang W, Lee KW, Srivastava RM, et al. Immunogenic neoantigens derived from gene fusions stimulate T cell responses. Nat Med. 2019;25:767–775.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
